Eli Lilly

Showing 7 posts of 202 posts found.


Eli Lilly appoints Richard Ascroft as senior director for the ACE region

November 30, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Lilly has appointed Richard Ascroft as senior director, corporate affairs, for the Australia, Canada and Europe (ACE) region. His tasks …

Blood clot fears halt cancer trial enrolment

February 3, 2011
Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer

Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …

Lilly Oncology chief resigns

January 27, 2011
Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …

Lilly and Boehringer sign major diabetes collaboration

January 12, 2011
Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes

Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …

Patient deaths halt Lilly cancer trial

December 15, 2010
Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …

UK pharma faces rising costs from value-based pricing

December 3, 2010
Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing

The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …

Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010
Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …

Latest content